Global Cetirizine Hydrochloride Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
8882
-
May 2023
-
188
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
“Global Cetirizine Hydrochloride Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global cetirizine hydrochloride market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global cetirizine hydrochloride market report has been segmented on the basis of dosage form, age group, application, distribution channel, and region.
Introduction
Cetirizine hydrochloride is an effective second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Compared to traditional antihistamines, it does not cause drowsiness or anticholinergic side effects. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions. Cetirizine hydrochloride is used for treating cold, allergy symptoms, itching, and swelling caused by hives.
Market Dynamics
Increasing incidence of allergic conditions such as allergic rhinitis among children and adult population is a major factor expected to drive growth of the cetirizine hydrochloride market over the forecast period. For instance, in 2018 according to the American College of Allergy, Asthma and Immunology – allergies are sixth leading cause of chronic illness in the US, with over 50 Mn people suffering from allergies annually.
In addition, rising technological advancements and data-driven customization in order to satisfy consumer demand for efficiency and accuracy are other factors expected to further full growth of the target market over the forecast period.
According to the Nutrition and Health Department, 2015, atopic dermatitis (AD), also known as atopic eczema – a common chronic inflammatory skin disease affecting 15-20% of children and 1-3% of adults globally. This factor is in turn expected to increasing prevalence of allergic conjunctivitis and eczema is a propel growth of the global market over the forecast period.
However, drug can induce severe to moderate side effects, include insomnia, unstable heartbeat, hyperactivity, nausea, constipation, and headache, which are factors expected to restrain adoption cetirizine hydrochloride over the forecast period.
Increasing investment by major manufacturers for R&D activities and rising mergers and acquisitions for technological advancements and development of innovative products are some factors expected to create potential revenue opportunities for players operating in the target market over the forecast period.
Analysis by Segment
On the basis of distribution channel segment, the Hospital Pharmacies is expected to dominate in terms of revenue over the forecast period, owing to increasing adoption of cetirizine hydrochloride across hospitals, clinics, and drug stores.
Analysis by Region
The market in North America is expected to dominate the global cetirizine hydrochloride in terms of revenue over the forecast period, owing to increasing economic burden due to prevalence of hay fever and allergic conjunctivitis across the US. The market in Europe is expected to register significant growth in terms of revenue over the forecast period. The market in
Global cetirizine hydrochloride market segmentation:
Segmentation by dosage form:
- Tablet
- Syrup
- Solution
Segmentation by age group:
- Adult
- Pediatric
Segmentation by application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
Segmentation by distribution channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- Johnson and Johnson
- UCB Pharma S.A
- Mylan, Inc.
- Strides Pharma Science Limited
- Apotex Inc.
- Teva UK Ltd.
- Aurobindo Pharma Limited
- Jubilant Life Sciences Limited
- Cipla Limited
- Sun Pharmaceutical Industries Limited
- Lunan Pharmaceutical Group Co., Ltd.
Our Clients
View Our Licence Options
